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Human cytomegalovirus (HCMV) reactivation from latency causes disease in individuals who are immunocompromised or immunosuppressed.
Activation of the major immediate-early (MIE) promoter is thought to be an initial step for reactivation. We determined whether expression of the
MIE gene products in transwas sufficient to circumvent an HCMV latent-like state in an undifferentiated transformed human promonocytic (THP)-1
cell model system. Expression of the functional MIE proteins was achieved with a replication-defective adenovirus vector, Ad-IE1/2, which contains
the MIE gene locus. Expression of the MIE proteins by Ad-IE1/2 prior to HCMV infection induced viral early gene expression accompanied by an
increase in active chromatin signals. Expression of the anti-apoptotic protein encoded by UL37x1 increased viral early gene expression. However,
viral DNA replication and production of infectious virus was not detected. As expected, cellular differentiation with phorbol 12-myristate 13-acetate
and hydrocortisone induced virus production. Cellular differentiation is required for efficient viral reactivation.
© 2007 Elsevier Inc. All rights reserved.Keywords: Human cytomegalovirus; HCMV; Latency; Reactivation; THP-1; IE72; IE86; UL37x1Introduction
Human cytomegalovirus (HCMV) is a β-herpesvirus and can
establish latency in an infected host. Primary infection or
reactivation from latency in immunocompromised individuals
with AIDS or in immunosuppressed patients undergoing organ
transplant therapy causes disease and can be fatal. Like other
herpesviruses, HCMV undergoes periodic reactivation to
produce infectious virus that is shed in bodily secretions (Sinclair
and Sissons, 2006).
HCMVestablishes latency in vivo in undifferentiated myeloid
lineage cells (Hahn et al., 1998; Kondo et al., 1994, 1996) where
the viral genome is maintained as a circular plasmid (Bolovan-
Fritts et al., 1999). The mechanisms for maintaining the latent
state of the viral episome and reactivating viral gene expression
are unclear, and no HCMV proteins have been linked to main-
taining the latent state. There is a very strong link between⁎ Corresponding author. Fax: +1 319 335 9006.
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Reactivation occurs upon differentiation of CD34+ progenitor
cells (Reeves et al., 2005a) or monocytes (Reeves et al., 2005b;
Soderberg-Naucler et al., 2001) into either macrophages or
dendritic cells (DCs). It has been reported that allogeneic
stimulation of latently infected peripheral blood monocytes
reactivates HCMV (Soderberg-Naucler et al., 1997). It is
assumed that induction of viral immediate-early (IE) gene
expression is the major rate-limiting step for HCMVreactivation
(Marchini et al., 2001; Meier and Stinski, 1997; Reeves et al.,
2005b).
The activity of the HCMV major immediate-early (MIE)
promoter is influenced by the differentiation state of the cell and
by various signal transduction pathways. The MIE promoter is
silenced in nonpermissive, undifferentiated CD34+ progenitor
cells, monocytes, and DC precursors and is associated with
repressive chromatin proteins such as heterochromatin protein 1
(HP1) and relatively high levels of histone deacetylases
(HDACs) (Murphy et al., 2002; Reeves et al., 2005a, 2005b).
In permissive, differentiated macrophages and mature DCs, the
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as acetylated histone 4 (Ac-H4) and relatively low levels of
HDACs (Murphy et al., 2002; Reeves et al., 2005a, 2005b).
There are multiple difficulties in studying latently infected
primary monocytes and DCs from healthy human donors. Only
0.004–0.01% of these cells carry latent viral genomes (Slobed-
man and Mocarski, 1999). Viral latency-specific transcripts
found in experimentally infected granulocyte–macrophage
progenitors are approximately 10-fold lower than viral genomes
(Hahn et al., 1998; Slobedman and Mocarski, 1999). A
conditionally permissive myelo-monocytic cell line, THP-1,
has been used as a convenient model system to study HCMV
quiescence and reactivation (Beisser et al., 2001; Lee et al.,
1999; Weinshenker et al., 1988). Undifferentiated THP-1 cells
are nonpermissive for HCMV replication (Lee et al., 1999). The
virus binds and enters the cell, and the viral genome is
transported to the nucleus, but the cells are silent for viral MIE
gene expression (Meier and Stinski, 1997). In undifferentiated
THP-1 cells, the MIE promoter region is associated with the
repressive chromatin signal dimethylated lysine 9 of histone 3
(M2K9-H3) (Ioudinkova et al., 2006).
Undifferentiated THP-1 cells become permissive, macro-
phage-like cells for viral replication upon differentiation (Lee
et al., 1999; Turtinen and Seufzer, 1994; Weinshenker et al.,
1988). THP-1 cells are differentiated by treatment with a phorbol
ester such as phorbol 12-myristate 13-acetate (PMA) and
hydrocortisone (HC) (Kohro et al., 2004; Lee et al., 1999).
The factors and signal transduction cascades important in
differentiation of THP-1 cells into macrophage-like cells are
unknown. Concomitant with THP-1 differentiation is expression
from the HCMV MIE promoter (Lee et al., 1999; Meier and
Stinski, 1997). It is assumed that early steps in differentiation of
conditionally permissive cells provide an increase in positive
regulators for MIE gene expression and a decrease in negative
regulators (Bain et al., 2003; Huang et al., 1996; Liu et al., 1994;
Shelbourn et al., 1989).
The MIE enhancer, which responds to cellular signals
associated with differentiation, is a genetic switch to induce the
expression of the viral MIE genes. The MIE promoter is
regulated by many cellular factors (Meier and Stinski, 1996),
including the human Daxx protein (Cantrell and Bresnahan,
2006; Preston and Nicholl, 2006; Saffert and Kalejta, 2006).
The HCMV MIE promoter regulates expression of the viral
IE72 protein from the IE1 gene and the IE86 protein from the
IE2 gene (Meier and Stinski, 1996).
For lytic viral replication, the IE72 protein is essential only at
low multiplicity of infection (MOI) (Greaves and Mocarski,
1998; Mocarski et al., 1996). The IE72 protein inhibits histone
de-acetylation (Nevels et al., 2004). The IE1 homolog in murine
CMV has been demonstrated to bind to HDAC2 and inhibit its
histone de-acetylase activity (Tang and Maul, 2003). The IE86
protein is an essential multifunctional protein that acts as a strong
transactivator of viral and cellular promoters (Lukac et al., 1997;
Marchini et al., 2001; Song and Stinski, 2002). The IE2 homolog
in murine CMV (ie3) is also essential (Angulo et al., 2000).
Given the necessity of the MIE proteins, IE72 and IE86,
during lytic infection and the knowledge that the MIE promoteris silenced in undifferentiated cells during latency, it may be
simple to presume that expression of the MIE proteins would
induce reactivation of HCMV. In fact, for herpes simplex virus
(HSV), ectopic expression of either IE protein infected cell
protein zero (ICP0) or ICP4 induced production of infectious
virus in a murine trigeminal ganglia latency model (Halford
et al., 2001). In addition, HCMV IE proteins were presumed
responsible for the reactivation of quiescent HSV, though this
has yet to be demonstrated (Russell and Preston, 1986; Stow and
Stow, 1989;Wigdahl et al., 1982). However, studies with murine
CMV suggest that reactivation may be more complex. At least
two steps are required for activation of the latent murine CMV
genome: (i) activation of the MIE enhancer and (ii) regulation of
alternative splicing of the ie1 and ie3 transcripts (Kurz and
Reddehase, 1999). Expression of the murine CMV ie1 and the
ie3 genes are necessary but not sufficient for reactivation from
viral latency in the mouse (Kurz and Reddehase, 1999). It is not
known whether expression of the HCMV MIE proteins is
sufficient for reactivation.
We examined whether expression of the HCMV MIE genes
would induce viral lytic events in undifferentiated THP-1 cells.
Viral MIE proteins were efficiently expressed in trans from a
replication-defective adenovirus vector in undifferentiated THP-
1 cells either prior to or after HCMV infection. To our
knowledge, there have been no reports of substantial expression
of HCMVMIE proteins in undifferentiated THP-1 cells infected
with HCMV. By expressing the MIE proteins in undifferentiated
THP-1 cells with Ad-IE1/2, we induced an artificial phenom-
enon. However, ectopic expression of theMIE proteins provided
a means to determine whether subsequent steps in viral rep-
lication occurred in undifferentiated THP-1 cells. Prior expres-
sion of theMIE proteins or the IE72 protein plus the IE86 protein
induced viral early gene expression. Viral early gene expression
was accompanied by an increase in active chromatin signals.
Increasing adenovirus vector MOI appeared to increase cell
death (unpublished data). We examined whether co-expressing
an HCMV IE anti-apoptotic protein, UL37x1 (Arnoult et al.,
2004), by using Ad-UL37x1 with Ad-IE1/2 would increase viral
early gene expression. Only at relatively high adenovirus MOI
did Ad-UL37x1 increase the ability of Ad-IE1/2 to induce viral
early gene expression. HCMV MIE gene expression was only
one of the rate-limiting steps to productive viral replication in
THP-1 cells. Additional checkpoints must be operating in THP-
1 cells because viral DNA synthesis and recovery of infectious
virus was not detected. In contrast, differentiation of THP-1 cells
with PMA and HC, added immediately after HCMV infection,
yielded infectious virus.
Results
Construction and functionality of adenovirus vectors
To express the HCMV IE72 and IE86 proteins together in
trans, we chose to construct a second-generation, replication-
defective adenovirus vector, Ad-IE1/2, which was deleted in E1a,
E1b, andE4. Second-generation adenovirus vectors have deletions
to the adenovirus genome in addition to the E1a and E1b deletions
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advantageous because they may accommodate larger trans-
genes and express fewer adenovirus genes that may confound
data interpretation (Cao et al., 2004). An adenovirus vector
expressing HCMV IE protein UL37 exon 1, Ad-UL37x1, was
also constructed. These HCMV transgenes were efficiently
expressed at MOIs as described in Materials and methods when
a transactivator, encoded on Ad-Trans, binds upstream of the
promoter. Ad-GFP served as an adenovirus vector control (Fig.
1A). Ad-IE1/2 expressed the MIE proteins, IE72 and IE86,
when transduced into primary human foreskin fibroblast (HFF)
cells or undifferentiated, promonocytic THP-1 cells (Figs. 1B
and C). Ad-UL37x1 expressed the UL37 exon 1 protein in
HFF cells or THP-1 cells (Figs . 1D and E). Expression of IE72
and IE86 could be detected in HFF cells as much as 10 days
after transduction (data not shown).Fig. 1. Replication defective adenovirus vectors and viral protein expression. (A) Ad
contains the UL37 exon 1 gene. Efficient expression of the transgene requires bindi
(TRE). The transactivator contains a tetracycline-responsive DNA-binding domain (t
gene expressed by a Rous sarcoma virus (RSV) promoter. (B–E) Cells were either in
subjected to Western blot analysis to detect IE72, IE86, and UL37x1 proteins as desc
tested in permissive HFF and nonpermissive, undifferentiated THP-1 cells.Several different assays were performed to demonstrate the
functionality of the IE72 protein or IE86 protein expressed from
Ad-IE1/2. Cellular promyelocytic leukemia (PML) protein
normally localizes to the nucleus as punctate domains; however,
wild-type HCMV IE72 disperses PML into a diffuse nuclear
pattern (Ahn et al., 1998; Ahn and Hayward, 1997). Ad-IE1/2
also dispersed PMLwhile theAd-GFP vector control did not (Fig.
2A). Both Ad-IE72 and Ad-IE1/2 rescued a recombinant virus
with the IE1 gene deleted (CR208) while Ad-GFP did not. As a
positive control, CR208 was assayed on immortalized human
fibroblasts expressing the IE1 gene, ihfie 1.3 cells (Table 1).
While there appear to be differences in the efficiency of rescue by
Ad-IE72 and Ad-IE1/2, both vectors likely rescued CR208 with
similar efficiency since it would be easy to miss the one or two
plaques expected at the highest dilution of CR208 for the Ad-
IE72 rescue.-IE1/2 contains the MIE gene locus from the HCMV Towne strain. Ad-UL37x1
ng of a transactivator expressed from Ad-Trans to the Tet-Responsive Element
etR) and a VP16 activation domain. Ad-GFP contains an enhanced GFP (eGFP)
fected with HCMVor transduced with Ad-IE1/2, Ad-GFP, or Ad-UL37x1, and
ribed in Materials and methods. IE72, IE86, and UL37x1 protein expression was
Fig. 2. Functional analysis of IE72 and IE86 proteins. (A) Immunofluorescence assay for ND10 dispersion by IE72. HFF cells were either infected with HCMVor
transduced with Ad-IE1/2 or Ad-GFP. 1 day later, cells were fixed, permeabilized, and double-labeled with anti-IE72 and anti-PML antibodies as described in
Materials and methods. The top and bottom panels are images of the same field. (B) Effect of Ad-IE1/2 on HCMVearly RNA in HFF cells. Cells were transduced in
replicate with Ad-IE1/2 or Ad-GFP. 1 day later, cells were incubated in 200 μg/ml CHX for 30 min prior to HCMV infection in the presence of CHX. The inoculum
was removed after 1 h and a medium containing CHX was added. Whole-cell RNA was harvested at 6 h PI and analyzed by real-time RT–PCR as described in
Materials and methods. Data reflects fold-change in level of HCMVearly RNA from Ad-IE1/2 transduced cells normalized to cellular 18S RNA (RNAN) and relative
to Ad-GFP RNAN. Mock-infected HFF and no RT samples were negative controls (data not shown). (C) Ad-IE1/2 rescue of Towne-BACΔ122. 1.24×10
6 HFF cells
were transfected with 5 μg Towne-BACΔ122 DNAwhich contains a GFP reporter driven by an SV40 early promoter. 1 day later, cells were transduced with Ad-IE1/2
or Ad-GFP. Cells were observed for plaques or green fluorescent foci. The two panels are of the same field. Ad-GFP did not produce plaques or green fluorescent foci
(data not shown). Images were taken approximately 25 days posttransfection with an Olympus BX-51 light microscope at 30× magnification.
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transcription as described previously from our laboratory
(Murphy et al., 2000). Ad-IE1/2 increased steady-state viral
early RNA relative to Ad-GFP. Ad-IE1/2 increased the steady-
state early RNA of RL7 (unknown function, β1.2 transcript),
UL54 (DNA polymerase), and UL44 (DNA processivity factor)
in HFF cells infected with HCMV in the presence of
cycloheximide (CHX) relative to Ad-GFP (Fig. 2B). Ad-IE1/2
rescued a replication-defective HCMV bacterial-artificial chro-
mosome (BAC) with the IE2 gene deleted (Towne-BACΔ122)
as determined by HCMV cytopathic effect (CPE) and GFP
expression from a viral promoter in multiple HFF cells (Fig. 2C).
In contrast, Ad-GFP had no effect (data not shown). Formation
of Towne-BACΔ122 plaques indicated that the IE86 protein was
fully functional.
Ad-UL37x1 expressed a functional anti-apoptotic protein,
demonstrated by HeLa cell survival after treatment with anti-Fas
plus CHXor TNF-α plus CHX (Personal communication, Victor
Goldmacher, ImmunoGen, Inc.). An Ad-Trans vector control
had little to no effect. These data indicate that the adenovirusvectors efficiently expressed the functional viral MIE and IE
proteins.
Effect of IE72, IE86, and UL37x1 proteins on viral early gene
expression in THP-1 cells
Upon HCMV infection of permissive HFF cells, viral IE
genes are initially expressed followed by viral early gene
expression. In contrast, infection of undifferentiated promono-
cytic THP-1 cells provides little to no MIE gene expression or
viral early gene expression (Meier and Stinski, 1997). It is
proposed that HCMV enters a latent-like state in THP-1 cells
because the viral genome is relatively quiescent and treatment of
infected cells with differentiation-inducing drugs will induce
temporal expression of viral genes and yield infectious virus
(Lee et al., 1999; Sissons et al., 2002). We examined whether
expression of the IE72 and IE86 proteins in trans, before or after
HCMVinfection, would prevent silencing of the viral genome in
undifferentiated THP-1 cells. Ad-IE1/2 was transduced into
undifferentiated THP-1 cells and infected with an HCMV
Table 1
Plaques formed by CR208 in HFF or ihfie 1.3 cells
Plaque forming units a
CR208 (PFU/ml) b HFF+Ad-GFP HFF+Ad-IE72 ihfie 1.3
7.2×103 TNTCc TNTC TNTC
7.2×102 37±6 TNTC TNTC
7.2×101 0 134±25 72±13
7.2 0 13±3 4±1
0.72 0 0 0
CR208 (PFU/ml) HFF+Ad-GFP HFF+Ad-IE1/2 ihfie 1.3
2.4×104 TNTC TNTC TNTC
2.4×103 34±4 TNTC TNTC
2.4×102 1±1 TNTC TNTC
2.4×101 0 TNTC 24±7
2.4 0 53±14 1±1
0.24 0 3±1 0
a HFF cells were transduced with 1 PFU/cell of adenovirus vector.
b The titer of CR208 was determined on ihfie 1.3 cells.
c Too numerous to count.
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amphenicol acetyl transferase (CAT) reporter expressed from a
viral early promoter (UL127). Ad-IE1/2 transduced cells were
infected with RVdlM-583/-694CAT at 6, 12, or 24 h after
transduction. Ad-IE1/2 increased CAT activity from the viral
UL127 promoter 21- to 30-fold compared to an Ad-GFP vector
control (Fig. 3A). When PMA and HC were added immediately
after HCMV infection, CAT activity was induced 10-fold or
higher than Ad-IE1/2 (data not shown).
Undifferentiated THP-1 cells transduced with Ad-IE1/2 and
infected with HCMV showed more cell death with increasing
adenovirus vector MOI (data not shown). To determine whether
expression of an HCMV IE anti-apoptotic protein would
increase viral early gene expression, we used Ad-UL37x1. At
relatively low adenovirus vector MOI, there was little to no
effect when adding Ad-UL37x1 to Ad-IE1/2. However, at
relatively high adenovirus vector MOI, Ad-IE1/2 plus Ad-
UL37x1 had 3-fold more CAT activity from the viral UL127
promoter than Ad-IE1/2 alone (Fig. 3B).
To determine if the IE72 protein or IE86 protein alone was
sufficient to induce viral early protein expression in undiffer-
entiated THP-1 cells, we transduced cells with Ad-IE72 or Ad-
IE86. Ad-IE72 alone or Ad-IE86 alone had little to no effect on
CAT activity while Ad-IE72 plus Ad-IE86 increased CAT
activity approximately 4- to 5-fold (Fig. 3C).
When THP-1 cells were transduced with Ad-IE1/2 and then
infected 24 h later with RVdlM-583/-694CAT, there was an
approximately 11-fold increase in CAT activity from the viral
early UL127 promoter (Fig. 3D). When we infected undiffer-
entiated THP-1 cells with RVdlM-583/-694CAT first and, after
24 h, transduced with Ad-IE1/2, there was little to no CAT
activity. THP-1 cells still expressed the MIE proteins when
infected with HCMV first and transduced with Ad-IE1/2 (see
Fig. 1C, lane 4). It appears that the HCMV genome established a
latent-like state before the expression of the MIE genes. Once a
latent-like state was established, MIE gene expression did not
reactivate viral early gene expression.To determine the percentage of THP-1 cells expressing viral
early genes, we used a recombinant HCMV, RVdlM-583/
-694GFP, expressing a GFP reporter from the viral early UL127
promoter. Undifferentiated THP-1 cells were transduced with
Ad-IE1/2 and, 24 h later, infected with RVdlM-583/-694GFP.
Ad-IE1/2 induced GFP in 0.1% of cells by flow cytometric
analysis. AnAd-Trans vector control had no effect. Ad-UL37x1,
at an intermediate MOI of 200, did not have an additive effect.
As a positive control, undifferentiated THP-1 cells were infected
with HCMV for 3 h and, immediately afterwards, treated with
PMA and HC to differentiate cells and induce reactivation of
latent-like virus. Cellular differentiation induced GFP in 3.3% of
cells (Table 2). This indicates that HCMV successfully infected
3.3% of undifferentiated THP-1 cells. The low rate of HCMV
infectivity of undifferentiated THP-1 cells is similar to results
reported previously (Turtinen et al., 1989).
These data indicate that increasing the MOI of the adenovirus
vector increases the level of viral early gene expression. The
IE72 and IE86 proteins, together, when expressed prior to
HCMV infection, are necessary and sufficient to induce viral
early gene expression in undifferentiated THP-1 cells. Viral
early gene expression is repressed without pre-expression of the
MIE genes. Ad-IE1/2 induces viral early protein expression in
only a small population of THP-1 cells.
Effect of IE72 and IE86 proteins on HCMV early RNA in
THP-1 cells
We examined whether the IE72 and IE86 proteins would
induce expression of HCMVearly RNA. Undifferentiated THP-
1 cells were transduced with Ad-IE1/2 or Ad-GFP and later
infected with HCMV Towne. Viral RNAwas analyzed by real-
time RT–PCR at 1 and 3 DPI. Ad-IE1/2 increased steady-state
HCMV RNA from 20- to 275-fold for the RL7, UL54, UL44,
and UL105 (helicase/primase) early genes. Ad-GFP had no
effect (Fig. 4). As a positive control, undifferentiated THP-1
cells were infected with HCMV and, immediately afterwards,
treated with PMA and HC. Cellular differentiation induced viral
early gene expression an additional 10-fold or more above Ad-
IE1/2 (data not shown). These data indicate that pre-expression
of the IE72 and IE86 proteins induce HCMVearly RNA in THP-
1 cells.
Effect of IE72 and IE86 proteins on chromatin signals on
HCMV DNA in THP-1 cells
While HCMV early genes are associated with repressive
chromatin during a latent-like infection in undifferentiated THP-
1 cells, early genes are associated with active chromatin during a
lytic infection in differentiated THP-1 cells (Ioudinkova et al.,
2006). We examined whether induction of viral early gene
expression by the IE1/IE2 gene products was accompanied by an
increase in active chromatin signals, Ac-H3 and M3K4-H3, on
viral early genes (Ebert et al., 2006; Myers et al., 2001).
Undifferentiated THP-1 cells were transduced with Ad-IE1/2
and, one day later, infected with HCMV. Ad-IE1/2 transduced
cells had 4- to 9-fold more Ac-H3 andM3K4-H3 associated with
Fig. 3. Effect of IE72, IE86, and UL37x1 proteins on viral early protein expression in undifferentiated THP-1 cells. Cells were mock-transduced or transduced in
replicate with Ad-IE1/2, Ad-GFP, Ad-UL37x1, Ad-IE72, Ad-IE86, or Ad-IE72 plus Ad-IE86 as described in Materials and methods. Adenovirus input was equalized
with Ad-GFP. 1 day later (B–D), or at the times indicated (A), cells were infected with RVdlM-583/-694CAT, which expresses CAT from the viral early UL127
promoter, and harvested 3 DPI. (A) Effect of IE72 and IE86 proteins from Ad-IE1/2 (MOI 1000) when infected with RVdlM-583/-694CAT at 6, 12, or 24 h after
transduction. The fold-increase relative to Ad-GFP is designated. (B) Effect of IE72 and IE86 plus UL37x1 at different MOIs. (C) Effect of IE72 or IE86 alone or
together at different MOIs. Student's t test analysis showed no significance (p>0.097) between Ad-GFP and Ad-IE72 alone or Ad-IE86 alone at an MOI of 200. (D)
Effect of IE72 and IE86 on HCMV infected THP-1 cells. Undifferentiated THP-1 cells were infected with RVdlM-583/-694CAT. 1 day later, cells were transduced
with Ad-IE1/2 or Ad-GFP (MOI 1000) and harvested 3 days later. For comparison, THP-1 cells were transduced first and infected as described above in parallel.
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vector control (Fig. 5). Ad-IE1/2 plus Ad-UL37x1 had
approximately 2- to 8-fold more Ac-H3 and M3K4-H3 than
Ad-GFP plus Ad-UL37x1. These data indicate that IE72 and
IE86 proteins induce active chromatin signals, Ac-H3 and
M3K4-H3, on HCMV early genes in undifferentiated THP-1
cells.
Effect of IE72 and IE86 proteins on HCMV DNA in THP-1
cells
We examined whether induction of viral early gene
expression by the IE72 and IE86 proteins induced other viral
lytic events such as HCMV DNA replication in THP-1 cells.
Cells were transduced with Ad-IE1/2 or Ad-GFP (MOI 250)
and, after 24 h, infected with HCMV Towne (MOI 260). HCMV
gB DNA was used as an indicator for viral genome amplifica-tion. HCMV DNA synthesis was analyzed by real-time
quantitative PCR for viral gB DNA at 1, 5, and 7 DPI. Ad-
IE1/2 transduced cells had similar viral gB DNA relative to Ad-
GFP at all times PI (Fig. 6). In contrast, differentiation with PMA
and HC, added immediately after HCMV infection, induced 4-
fold more gB DNA at 7 DPI. These data indicate that pre-
expression of the IE72 and IE86 proteins was insufficient to
induce viral DNA synthesis in THP-1 cells.
Effect of IE72 and IE86 proteins on production of infectious
HCMV from THP-1 cells
To determine whether the IE72 and IE86 proteins could
induce small levels of infectious HCMV from undifferentiated
THP-1 cells, we co-cultured treated THP-1 cells with permissive
HFF cells. Undifferentiated THP-1 cells were transduced with
Ad-IE1/2 or Ad-Trans and later infected with RVdlM-583/
Table 2
Expression of GFP and recovery of infectious virus








Ad-Trans RVdlM-583/-694GFP 0.000±0.000 0.0±0.0 c











– RVdlM-583/-694GFP 0.000±0.000 0.0±0.0 f
a Cells were analyzed by flow cytometry after 3 days.
b HFF plaques were counted 9 days post co-culture.
c, f Due to the infrequent GFP+ THP-1 cells present, less than 35 GFP+ THP-1
cells on average were co-cultured with HFF cells.
d, e Student’s t test analysis showed no significance (p>0.206) of plaques.
Fig. 4. Effect of IE72 and IE86 proteins on HCMV early RNA in
undifferentiated THP-1 cells. Cells were transduced in replicate with Ad-IE1/
2 or Ad-GFP. 1 day later, cells were infected with HCMV Towne. Whole-cell
RNA was harvested at 1 or 3 DPI and analyzed by real-time RT–PCR as
described in Materials and methods. Data are HCMVearly RNA from Ad-IE1/2
transduced cells normalized to cellular 18S RNA (RNAN) and relative to Ad-
GFP RNAN. Mock-transduced THP-1 and no RT samples were negative
controls (data not shown).
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at 3 DPI by flow cytometry and co-cultured with permissive HFF
cells. HFF cells were observed for green fluorescent plaques.
There was little to no difference between cells transduced with
Ad-IE1/2 and Ad-Trans (Table 2). Ad-IE1/2 had only a mean of
4 foci per 1000 GFP+ THP-1 cells, Ad-IE1/2 plus Ad-UL37x1
had no foci, and Ad-IE72 plus Ad-IE86 had only a mean of 1.5
foci. In contrast, PMA and HC, added immediately after HCMV
infection, induced approximately 40 foci per 1000 GFP+ THP-1
cells. These data indicate that while Ad-IE1/2 can induce viral
early gene expression, it cannot induce infectious virus
production. The absence of infectious virus also confirms our
observation of a block at viral DNA replication. In contrast,
PMA andHC induced efficient infectious virus production in the
monocytic THP-1 cells.
Discussion
Human herpesviruses have evolved a means to persist for the
life of their host by establishing latency. When conditions are
opportune, herpesviruses will occasionally reactivate and
spread to other hosts. While HCMV follows this pattern, little
is known about the cellular and viral proteins required for
reactivation.
Select viral proteins have a key role in the initial stages of
switching from latency to reactivation and the lytic cycle.
Epstein–Barr Virus (EBV), a γ-herpesvirus, expresses IE
transactivators Z (Zebra or ZTA) and R (RTA) protein. Ectopic
expression of either Z or R protein induces lytic gene expression
in latently infected B lymphocytes (Countryman and Miller,
1985). Kaposi's sarcoma-associated herpesvirus (KSHV), also
a γ-herpesvirus, expresses an IE homolog of EBV R protein
called ORF50 (KSHV RTA). Ectopic expression of ORF50
induces early and late KSHV lytic gene expression in latently
infected B cells (Lukac et al., 1998; Sun et al., 1998). For HSV,an α-herpesvirus, ectopic expression of either IE ICP0 or ICP4
induces production of infectious virus from latently infected
murine trigeminal ganglia (Halford et al., 2001).
These same viral IE transactivators likely facilitate transcrip-
tion by interacting with cellular chromatin-modifying proteins.
EBV Z protein (Adamson and Kenney, 1999; Zerby et al., 1999)
and R protein binds to CREB-binding protein (CBP) (Swenson
et al., 2001). KSHV ORF50 protein binds to CBP and HDAC1
(Gwack et al., 2001; Hwang et al., 2001). HSV ICP0 protein
binds to and inhibits class II HDACs (Lomonte et al., 2004).
Viral IE transactivators likely facilitate chromatin rearrange-
ment during reactivation by binding to chromatin modifying
proteins.
Our system was designed to bypass two early checkpoints
described for mouse cells latently infected with murine CMV in
vivo. Kurz and Reddehase (1999) reported that reactivation of
murine CMV from latency required (i) activation of the MIE
enhancer containing promoter and (ii) alternative splicing
events to express both the ie1 and ie3 genes. Latently infected
cells expressing the ie1 gene alone did not induce viral early
gene expression. By using replication defective adenovirus
vectors, we were able to ectopically express IE72, IE86, or both
MIE proteins of HCMV without requiring activation of the MIE
enhancer containing promoter and alternative mRNA splicing.
Based on our results, we propose that both β-herpesvirus
HCMV IE72 and IE86 proteins are required to function as a
switch for reactivation of viral early gene expression. Like other
herpesvirus IE proteins, HCMV IE72 and IE86 transactivate
viral early gene expression (Murphy et al., 2000; Nevels et al.,
2004). Both murine CMV ie1 and ie3 gene expression in vivo
were required for reactivation of viral early gene expression in
latently infected murine cells, but ie1 expression alone did not
(Kurz and Reddehase, 1999). Ectopic expression of HCMV
IE72 and IE86 proteins, together, but not individually, induced
viral early gene expression in human promonocytic THP-1
Fig. 5. Effect of IE72 and IE86 proteins on active chromatin signals associated with HCMVearly genes in undifferentiated THP-1 cells. Cells were mock-transduced
or transduced with Ad-IE1/2 or Ad-GFP (MOI 100). 1 day later, cells were infected with HCMV Towne. Cells were harvested at 2 or 3 DPI and subjected to
chromatin immunoprecipitation with antibodies to (A–C) Ac-H3, (D–F) M3K4-H3, or IgG isotype control antibodies and analyzed in replicate by real-time PCR for
HCMV RL7, UL54, and UL44 DNA as described in Materials and methods. Data are HCMV DNA normalized to GAPDH DNA input (DNAN) and depicted
relative to Ad-GFP DNAN or Ad-GFP plus Ad-UL37x1 DNAN. UL54P denotes an amplicon that includes the UL54 promoter. Student's t test analysis showed
significance (p<0.014) between Ad-GFP versus Ad-IE1/2 and Ad-GFP plus Ad-UL37x1 versus Ad-IE1/2 plus Ad-UL37x1 for all samples.
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with murine CMV is that the murine IE proteins are functionally
different during reactivation versus a productive infection in
permissive cells. We find this interpretation unlikely as the
HCMV IE72 plus IE86 proteins induced viral early gene
expression from the viral genome in both permissive HFF cells
in the presence of an inhibitor of proteins synthesis (Murphy et
al., unpublished data) and undifferentiated THP-1 cells in the
absence of an inhibitor of protein synthesis.While ectopic expression of IE72 and IE86 proteins in the
undifferentiated THP-1 cells circumvented quiescence, viral
DNA replication was not detected by real-time quantitative
PCR, and recovery of infectious virus was rare relative to
treatment with differentiation reagents PMA and HC. These
data indicate that induction of viral early gene expression is
either insufficient to induce viral DNA replication in THP-1
cells or that the newly synthesized viral DNA is quickly
degraded.
Fig. 6. Effect of IE72 and IE86 proteins on HCMV DNA in undifferentiated
THP-1 cells. Cells were mock-transduced or transduced in replicate with Ad-
IE1/2 or Ad-GFP. 1 day later, cells were infected with HCMV Towne. At 1, 5, or
7 DPI, DNAwas isolated and analyzed by real-time PCR for HCMV gB DNA.
Data are normalized to cellular 18S DNA (DNAN) and depicted relative to Ad-
GFP gB DNAN at 1 DPI. PMA and HC were added immediately after the viral
absorption period.
182 L.-F. Yee et al. / Virology 363 (2007) 174–188The block to viral DNA synthesis is not due to nonfunctional
IE72 or IE86 proteins. Ad-IE1/2 significantly increased viral
early gene expression and the intercellular adhesion molecule
(ICAM)-1 in undifferentiated THP-1 cells. Undifferentiated
THP-1 cells transduced with Ad-IE1/2 and infected with
RVdlM-583/-694GFP that were GFP+ had approximately 5-
fold more ICAM-1+ cells than Ad-Trans-transduced cells, which
were GFP- (L.-F. Yee and M. F. Stinski, data not shown). The
IE86 and IE55 proteins likely increase ICAM-1 expression in
undifferentiated THP-1 cells as demonstrated in other cell types
(Chan et al., 2004; Kronschnabl and Stamminger, 2003).
Cellular factors induced or reduced by differentiation are
likely critical for viral DNA replication and production of
infectious virions such as a reduction in cellular concentrations
of HDACs (Murphy et al., 2002; Reeves et al., 2005b). HCMV
has been demonstrated to regulate the cell cycle (Murphy et al.,
2000; Song and Stinski, 2005). It is possible that HCMV is
unable to manipulate the cell cycle in the undifferentiated THP-1
cells for efficient viral replication.
The MIE proteins were inefficient at circumventing quies-
cence when undifferentiated THP-1 cells were first infected with
HCMV RVdlM-583/-694CAT and then, a day later, transduced
with Ad-IE1/2. Under these conditions, little to no viral early
gene expression was detected. However, when the MIE proteins
were expressed prior to HCMV infection, viral early gene
expression was induced, which correlated with active chromatin
signals on early genes. These data imply that pre-expression of
the HCMV MIE proteins prevented the establishment of a
repressive chromatin configuration on the viral genome.
The inefficiency of theMIE proteins to circumvent quiescence
in THP-1 cells, even after a high MOI, is likely indicative of a
strong heterochromatin structure that forms quickly on the viral
genome in the undifferentiated cell (Ioudinkova et al., 2006;Meier, 2001; Murphy et al., 2002; Reeves et al., 2005a, 2005b).
Heterochromatin repression of the HCMV MIE promoter is
believed to be mediated by binding of cellular repressors such
as Ets-2 repressor factor (ERF) (Bain et al., 2003), Yin Yang
(YY)1 (Liu et al., 1994), modulator binding factor (MBF)1
(Kothari et al., 1991; Shelbourn et al., 1989; Sinclair et al.,
1992), and modulator recognition factor (MRF) (Huang et al.,
1996) to cis-acting elements such as the 21-bp repeats and the
modulator upstream of the promoter. Potential positive acting
factors include MBF2 and MBF3 (Shelbourn et al., 1989). The
effects of many of these repressors were studied using reporter
based plasmids. Some of these repressors such as ERF (Wright
et al., 2005) and human Daxx (Saffert and Kalejta, 2006) may
modify chromatin structure by recruiting HDACs, thereby
silencing the MIE promoter. However, there is likely redun-
dancy in function because deletion of the 21-bp repeats or the
modulator in the context of a recombinant virus does not relieve
repression of the MIE promoter in undifferentiated NTera2 cells
(Meier, 2001). Results with reporter based plasmids may not be
representative of results observed in the context of the viral
genome.
The virion-associated pp71 protein relieves repression of the
MIE promoter by degrading the human Daxx repressor (Saffert
and Kalejta, 2006). In-coming virion associated proteins such as
pp71 were not sufficient to neutralize an intrinsic defense
mechanism in undifferentiated THP-1 cells as seen by silencing
of the viral genome. Similar results were found with a
conditionally permissive, undifferentiated neuroteratocarci-
noma cell line, NTera2 cells, infected with HCMV (Gonczol
et al., 1985; Meier, 2001). Interestingly, we were unable to
induce viral DNA synthesis with pre-expression of the MIE
proteins plus UL37x1 or the MIE proteins plus pp71 using Ad-
pp71 in THP-1 cells (L.-F. Yee and M. F. Stinski, data not
shown).
We were only able to efficiently bypass the repressive
mechanisms by expressing the MIE proteins prior to HCMV
infection in undifferentiated THP-1 cells. The MIE proteins thus
appear necessary to prevent the establishment of a latent-like
state, but are insufficient to reactivate virus from a latent-like
state using the HCMV Towne strain. In contrast, switch proteins
for α- or γ-herpesviruses are necessary and sufficient for
inducing lytic gene expression when ectopically expressed after
viral infection.
The ability to overcome genomic silencing required functions
of both the IE72 and IE86 proteins expressed prior to HCMV
infection. The requirement for the viral IE86 protein was
expected because it is essential for viral early gene expression
and is a strong transactivator (Bresnahan et al., 1998; Lukac
et al., 1997; Marchini et al., 2001; Song and Stinski, 2002). The
HCMV IE86 protein also interacts with chromatin modifying
proteins, CBP and p300/CBP-associated factor (P/CAF) (Bryant
et al., 2000; Schwartz et al., 1996). The requirement for the viral
IE72 protein was less definitive. However, the IE72 protein
dispenses PML in the nucleus (Ahn et al., 1998) and antagonizes
histone de-acetylation (Nevels et al., 2004). The IE72 homolog
in murine CMV, murine IE1, has been proposed to create a
privileged space for transcription of the viral genome; all viral
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by HDACs (Tang et al., 2005; Tang and Maul, 2003). The
requirement of the IE72 protein underscores the necessity to
neutralize the intrinsic cellular defense mechanism for success-
ful viral lytic gene expression. Increasing the level of IE72 and
IE86 protein expression by increasing theMOI of the adenovirus
vectors had negative effects on the THP-1 cells unless the viral
anti-apoptotic UL37x1 gene product was also expressed.
Additional checkpoints must be operating in THP-1 cells
because the recovery of infectious virus was a rare event. These
observations are consistent with the multistep model of murine
CMV reactivation where progression to early reactivation
checkpoints does not obligate production of infectious virus
(Kurz and Reddehase, 1999; Simon et al., 2005, 2006). The
expression of the HCMV MIE genes is not solely sufficient to
induce progression to infectious viral replication. This suggests
that sporadic expression of HCMV MIE genes in vivo would
also not be sufficient to signal viral reactivation and replication
as demonstrated withmurine CMV (Kurz andReddehase, 1999).
It is unlikely that the MIE proteins fully differentiate THP-1
cells because there was little to no production of infectious
HCMV compared to differentiation with PMA and HC. In
addition, it has been demonstrated that inducing differentiation
of THP-1 cells prior to HCMV infection substantially increases
HCMV lytic events compared to treating cells with differentiat-
ing reagents immediately after infection (Lee et al., 1999). If the
MIE proteins fully differentiate THP-1 cells, it would be
expected that transduction with Ad-IE1/2 and, a day later,
infection with a recombinant HCMV, RVdlM-583/-694GFP,
would induce substantially more GFP+ cells than infection with
RVdlM-583/-694GFP followed immediately afterwards with
treatment with PMA and HC. This did not occur and this
indicates that the MIE proteins do not induce THP-1 differentia-
tion (Table 2).
The rescue of latent virus from clinically infected primary
myeloid cells (Reeves et al., 2005b; Soderberg-Naucler et al.,
1997) or experimentally infected promonocytic THP-1 cells is
an extremely rare event. These experiments suggest that
reactivation of HCMV from quiescence may require completion
of the cellular differentiation pathway from blood monocytes to
DCs or macrophages. Promonocytic THP-1 cells expressing the
viral MIE proteins were limited to viral early gene expression
whereas the PMA and HC treated THP-1 cell reached a level of
differentiation more favorable to viral DNA synthesis and
infectious virus production.
Materials and methods
Cell culture, virus, and adenovirus vectors
Primary HFF cells were grown in Eagle's minimal essential
medium (Mediatec, Herndon, VA) supplemented with 10%
newborn calf serum (Sigma, St. Louis, MO), penicillin (100 U/
ml), and streptomycin (100 μg/ml). Undifferentiated THP-1 cells
were obtained from American Type Culture Collection (ATCC,
Manassas, VA) and grown in RPMI 1640 medium (Mediatec)
supplemented with 10% fetal bovine serum (FBS) (Hyclone,Logan, UT), penicillin, and streptomycin. Fresh THP-1 cells
were obtained from ATCC after approximately 16 passages.
Disposable plastic pipettes were used to prevent lipopolysac-
charide-induced differentiation. THP-1 cells were differentiated
by incubating in 20 nM phorbol 12-myristate 13-acetate (PMA)
(Sigma) and 50 μM hydrocortisone (HC) (Sigma) immediately
after a 3-h HCMV absorption period. HFF and THP-1 co-
cultures were grown in Eagle's minimal essential medium
(Mediatec) supplemented with 10% FBS (Hyclone), penicillin,
and streptomycin. E1a-, E1b-, and E4orf6-expressing MBC55
cells from theUniversity of Iowa (UI) Vector Corewere grown in
Dulbecco's medium supplemented with 10% FBS, penicillin,
streptomycin, and 500 μg/ml G418 (Invitrogen, Carlsbad, CA);
E4orf6 expression was induced with 20 μM dexamethasone
(Sigma) (Gao et al., 1996). E1a-, E1b-, and E4orf6-expressing
10-3 cells from the University of Pennsylvania Vector Core were
grown the same as the MBC55 cells except in the absence of
G418, and E4orf6 expression was induced with 150 μM ZnSO4
(Mallinkrodt, St. Louis, MO) (Gao et al., 1996). 293 and IE72-
expressing ihfie 1.3 cells (a gift from E. Mocarski, Stanford
University) were grown in Dulbecco's medium supplemented
with 10% FBS (Sigma), penicillin, and streptomycin.
E1a−, E1b−, E4− adenovirus vectors were propagated in either
MBC55 or 10-3 cells (Gao et al., 1996). E1a− E1b− adenovirus
vectors were propagated in 293 cells. Replication-defective
E1a−, E1b−, E4− adenovirus vectors Ad-GFP, Ad-Trans, andAd-
IE1/2 or E1a− E1b− Ad-UL37x1 were constructed as described
previously (Anderson et al., 2000). A Tet-Responsive Element
(TRE) upstream of a minimumCMV promoter containing the cis
repression sequence (crs) from the XhoI to EcoRI sites of
plasmid pTRE2 (Clontech, Mountain View, CA) was inserted
into pAd5mcspA shuttle vectors (UI Vector Core). TheMIE gene
locus from the EagI to SalI sites of plasmid pSVCS (Malone
et al., 1990) was inserted to make the AdIE1/2 shuttle vector,
pAd5mdspA-TetIE1/2. TheAd-UL37x1 shuttle vector, pAd5mc-
spA-TetUL37x1, was constructed by a series of subclones. The
UL37x1 ORF (approximately 910 bp) from the BbsI to HindIII
sites of plasmid pAI28 (a gift from D. Anders, Wadsworth
Center) was inserted into pBlueScript II KS+ (Stratagene, La
Jolla, CA), and then an approximately 940-bp, SalI to XbaI,
UL37x1 fragment was inserted into pAd5mcspA-Tet.
The E1a−, E1b−, E4− Ad-Trans shuttle vector, pAd5mcspA-
TetOff, was cloned by inserting an XhoI to HindIII fragment
containing the Tet-Off transactivator from pTet-Off (Clontech)
into pAd5mcspA. DNA sequencing of the 5′ and 3′ ends of the
transgene in each adenovirus shuttle vector were found to be
correct (data not shown). E1a−, E1b−, E4− Ad-GFP was obtained
from the UI Vector Core.
Adenovirus vectors were plaque purified once. Replication
defective E1a−, E1b−, and E3− adenovirus vectors Ad-GFP, Ad-
Trans, Ad-IE72, and Ad-IE86 were described previously
(Murphy et al., 2000). The titers of the recombinant adenovirus
vectors were determined by plaque assay on complementing cell
lines and particle count with an A260 reading (Anderson et al.,
2000;Mittereder et al., 1996). Adenovirus vectors were used at a
MOI of 2 to 10 for transduction of HFF cells or a MOI of 50 to
1000 for transduction of THP-1 cells. Approximately 68,183
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and 85% of the transduced THP-1 cells expressed the indicator
gene GFP (see Table 2). The adenovirus vector control, Ad-GFP,
was used at the sameMOI as our experimental vector, Ad-IE1/2.
In addition, Ad-Trans was cotransduced with Ad-GFP at the
same MOI used for Ad-IE1/2. This procedure not only allowed
for equivalent adenovirus input between control and experi-
mental samples, but also controlled for any effect of Ad-Trans.
Ad-Trans was used to equalize adenovirus input for GFP studies.
Adenoviruses were transduced with 3 μl/ml Lipofectamine
reagent (Invitrogen). After 1 to 3 h at 37 °C, the inoculum was
removed and the cells were maintained in complete media. Pre-
expression of adenovirus transgenes prior to HCMV infection
was achieved by transducing cells about 24 h prior to infection.
Propagation of HCMV Towne, RVdlM-583/-694CAT,
RVdlM-583/-694GFP, and Towne-BACΔ122 (a gift from H.
Zhu, Princeton University) have been described previously
(Isomura and Stinski, 2003; Marchini et al., 2001; Stinski,
1977). Towne-BACΔ122 was transfected into HFF cells at
200 V with a pulse length of 27 ms using a BTX 830
electroporator (Harvard Applications, Holliston MA) as
described previously (Morello et al., 1999). Recombinant virus
CR208 (a gift from E. Mocarski, Stanford University) was
propagated in ihfie 1.3 cells as described previously (Greaves
and Mocarski, 1998). HCMV wild-type and recombinant
viruses were used at a MOI of 1 to 10 for infection of HFF
cells or a MOI of 50 to 500 for infection of THP-1 cells. HCMV
was allowed to absorb for 1 h (HFF) or 3 h (THP-1) at 37 °C
before cells were washed and incubated in complete media.
Western blot analysis
Cells were collected, fractionated, and transferred to
nitrocellulose membranes as described previously (Murphy
et al., 2000). Cells were harvested 1 to 3 days post-infection
(DPI) or post-transduction. Lysates were fractionated on a
sodium dodecyl sulfate (SDS) 9% or 12% polyacrylamide gel.
Primarymouse monoclonal antibody (MAb) NEN 9221 (Perkin-
Elmer Life Sciences, Boston,MA) or 810 (Chemicon, Temecula,
CA) at 1:500 dilution and secondary sheep anti-mouse IgG
peroxidase-labeled antibody (Amersham Biosciences, Piscat-
away, NJ) at 1:20,000 dilution were used for the detection of the
IE72 and IE86 proteins. Primary rabbit serum #312 or #313 (a
gift from V. Goldmacher, ImmunoGen, Cambridge, MA) at
1:1000 dilution at 4 °C overnight and secondary donkey anti-
rabbit peroxidase-labeled IgG antibody (Amersham Bios-
ciences, Piscataway, NJ) at 1:10,000 dilution at room tempera-
ture for 1 h were used for detection of the UL37x1 protein.
SuperSignal West Pico chemiluminescent substrate (Pierce,
Rockford, IL) was used in accordance with the manufacturer's
directions.
CAT assay
CATenzyme activities were determined in substrate excess as
described previously (Gorman et al., 1982). Either 1×106 or
1.5×106 THP-1 cells were used. The acetylated and unacety-lated [14C]chloramphenicol (Perkin-Elmer Life Sciences) were
separated by thin-layer chromatography in a chloroform–
methanol (95:5) solvent. The amount of [14C]chloramphenicol
acetylation was determined by image acquisition analysis on a
Packard Instant Imager (Packard Instrument Co., Meriden, CT),
and protein concentration was determined by the Bradford
method (Bio-Rad Laboratories, Richmond, CA).
Immunofluorescence assay
Cells were fixed, permeabilized, and probed with antibodies
as described previously (Ahn et al., 1998; Ahn and Hayward,
1997). Cells were fixed 24 h PI or post-transduction with 1%
paraformaldehyde at 20 °C for 5min and permeabilized with ice-
cold 0.2% Triton X-100 for 20 min. Cells were washed with 1×
phosphate-buffered saline (PBS) and double-labeled with
primary anti-IE72 mouse MAb 6E1 (Vancouver Biotechnology,
Vancouver, Canada) at 1:200 dilution and rabbit anti-PML
Nuclear Dot Protein polyclonal antibody (Chemicon) at 1:200
dilution at 37 °C for 1 h. Cells were labeled with secondary
antibodies (1:100) FITC-labeled goat anti-mouse IgG and
rhodamine-coupled goat anti-rabbit IgG (Santa Cruz, Santa
Cruz, CA), respectively, at 37 °C for 45 min. Cells were
visualized under oil immersion with an Olympus BX-51 light
microscope at 600× magnification using Spot Advance software
(Diagnostic Instruments, Sterling Heights, MI).
Real-time PCR
Total-cell RNAwas isolated and analyzed by multiplex RT–
PCR as described previously (Meier et al., 2002). Whole-cell
RNA was isolated from 1×106 THP-1 cells as described
previously (Chomczynski and Sacchi, 1987) or with TRI
Reagent according to themanufacturer's instructions (Molecular
Research Center, Cincinnati, OH). RNAs were treated with
RNase-free DNase I (Promega, Madison, WI) at 37 °C for
30 min. Superscript II RNase H-negative reverse transcriptase
(Invitrogen) and random hexamers (Invitrogen) were used to
generate cDNA from an equal amount of RNA. Reverse
transcriptase was omitted as a control to detect any undegraded
input DNA. Multiplex real-time PCR was performed using the
ABI PRISM 7700 Sequence Detection System (Applied
Biosystems, Foster City, CA) for simultaneous detection of
probes containing 6-carboxyfluorescein (FAM) and VIC
reporter fluorophores. Each reaction mixture contained 2 μl
diluted template (1:5) and 20 μl of Platinum Quantitative PCR
SuperMix-UDG cocktail (Invitrogen) prepared according to the
manufacturer's directions. The final 25 μl reaction contained
5 mMMgCl2, 400 nM each target primer, 200 nM target probe,
5 nM each 18S primer, 40 nM 18S probe, and 1× ROX reference
dye. Primers and probes (Integrated DNA Technologies [IDT],
Coralville, IA) were described previously (Petrik et al., 2006).
UL105 primers and probe are described in Table 3. Cellular 18S
rRNA served as the endogenous control. The primers used to
amplify the intronless ribosomal 18S cDNA and the VIC-labeled
probe used for detecting this amplicon were obtained from
Applied Biosystems. Threshold cycle (CT) values of samples not
Table 3
Real-time primers and probes a
Target Forward primer Reverse primer Probe
RL7 GCCGAGAGAATGCCAGTAAGA GGTTATTCGCTGGTTCGTTCTAA FAMb-CGACCATCGCAGACACAGTACGATACTCA-TAMRAc
UL54 TTGCGGGTTCGGTGGTTA CGGCCATAGTGTTGAGCTTATAGTT FAM-TACCCTGTATGCATGGCCAAGACTAACTCG-TAMRA
UL54Pd GCAGCCGTCCCGTCTTATG CGCGAGGTGTCATGTTCGA FAM-TCAACCCCGTCTGACC-MGBe
UL44 TTTTCTCACCGAGGAACCTTTC CCGCTGTTCCCGACGTAAT FAM-AGCGTGGCGATCCCTTCGACAAA-TAMRA
UL105 GGACGCCGAACTCATGGA GGTGGCTTGACGTATTTGAGAAA FAM-CACACCAGTCTGTACGCGGATCCCT-TAMRA
GAPDH CTCGAGGAGAAGTTCCCCAAC CTGCCCCCTCCCCTTTC JOE f-TTCCCGCCTCTCAGCCTTTGAAAGA-BHQ1g
a All sequences are 5′ to 3′.
b FAM, 6-carboxyfluorescein.
c TAMRA, tetramethyl rhodamine.
d UL54P amplifies UL54 promoter region.
e MGB, minor groove binding protein.
f JOE NHS Ester, 6-carboxy-4′, 5′-dichloro-2′,7′-dimethoxyfluorescein.
g BHQ1, black hole quencher 1.
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samples, did not appreciably differ from the baseline.
For multiplex real-time quantitative PCR, total-cell DNAwas
isolated as previously described (Isomura and Stinski, 2003)
using a PCR lysis buffer containing 10 mM Tris–HCl, pH 8.0,
1mMEDTA, 0.001%TritonX-100, 0.0001%SDS, and 50μg/ml
proteinase K (New England Biolabs, Beverly, MA). THP-1 cells
(1×106) were washed with 1× PBS, lysed in 200 μl lysis buffer,
and incubated at 55 °C for 100min to digest protein. Proteinase K
was inactivated at 95 °C for 10 min. DNA was purified with
phenol–chloroform and ethanol precipitated. Template DNA
(0.25 μg) in 5 μl was used in each 25 μl real-time PCR reaction.
The final reaction contained 5 mM MgCl2, 32 mM each gB
primer, 100 nM gB probe, 16 nM each 18S primer, 80 nM 18S
probe, and 1× ROX. Primers and probe recognizing gB DNA
have been described (Isomura and Stinski, 2003). Primers and
probe recognizing cellular 18S DNA as an endogenous control
were obtained from Applied Biosystems.
Singleplex real-time PCR was performed for chromatin
immunoprecipitation (ChIP) analysis. Each reaction mixture
contained 1 μl template isolated from ChIP and 20 μl of
Platinum Quantitative PCR SuperMix-UDG cocktail (Invitro-
gen) prepared according to the manufacturer's directions. The
final 25 μl reaction contained 5 mM MgCl2, 400 nM each viral
early target primer, 200 nM viral early target probe, and 1× ROX
reference dye. DNA input was analyzed by real-time PCR using
5 nM each GAPDHprimer and 40 nM probe (IDT). GAPDH and
UL54P primers and probes are described in Table 3.
Flow cytometric analysis
For differentiation markers, cells were analyzed as described
previously (Gredmark and Soderberg-Naucler, 2003; Isomura
and Stinski, 2003). THP-1 cells (1×106) were washed with cold
FACS buffer consisting of 1× PBS, 1% FBS, and 0.1% sodium
azide (Sigma). Cells were incubated in 100 μl antibody diluted in
FACS buffer on ice for 30 min. ICAM-1 was detected using
APC-conjugated ICAM-1 (CD54) antibody 559771 (BD
Pharmingen, San Diego, CA) (2 μl/test) and APC isotype
control antibody 555751 (BD Pharmingen) (2 μl/test). Cells
were washed twice with FACS buffer. Cells were fixed withFixation Reagent A (Caltag Laboratories, Burlingame, CA) for
15 min at room temperature or simply resuspended in FACS
buffer and kept on ice. Finally, cells were passed through a
70 μm nylon cell strainer (Becton Dickinson, Franklin Lakes,
NJ) before analysis on a LSR II flow cytometer (Becton
Dickinson). At least 200,000 cells were counted for the
adenovirus transduction followed by HCMV infection experi-
ment with an average of 146GFP+ cells transducedwith Ad-IE1/
2 examined in triplicate. List mode data were acquired with
CellQuest software (Becton Dickinson) and analyzed with
FlowJo software (Tree Star, San Carlos, CA).
For GFP expression and sorting, cells were analyzed as
described previously (Meier, 2001). THP-1 cells (1–6×106)
were washed with complete media without phenol red and GFP+
cells were separated from GFP− cells using a FACS DiVa flow
cytometer (Becton Dickinson). List mode data were acquired
with BD FACS DiVa software (Becton Dickinson) and analyzed
as described above.
For the infectious focus assay, cells were analyzed as
described previously (Meier, 2001). THP-1 cells (1–6×106)
were washed as described for GFP sorting at 3 DPI and sorted
into GFP+ or GFP− populations with a FACS DiVa flow
cytometer. GFP+ or GFP− THP-1 cells (76–908) were co-
cultured with HFF cells at a ratio of 1:1000. All samples were fed
at 4 DPI. The positive control was fed with media containing
PMA and HC. Co-cultured HFF cells were observed for CPE or
green fluorescent foci.
Chromatin immunoprecipitation
Cells were cross-linked, sonicated, and chromatin immuno-
precipitated as described previously (Lavrrar and Farnham,
2004). Briefly, 8×106 THP-1 cells were cross-linked with 1%
formaldehyde in 1× PBS for 10 min at room temperature. Cross-
linking was quenched for 5 min with 0.125 M glycine. Cells
were washed in ice-cold 1× PBS and then incubated for 20 min
on ice in 3ml cell lysis buffer (5 mMPIPES pH 8.0, 85mMKCl,
and 0.5% NP40) containing 1× Complete Mini protease
inhibitor (Roche Applied Science, Indianapolis, IN). Nuclei
were pelleted, suspended in 300 μl nuclei lysis buffer (50 mM
Tris–Cl, pH 8.1, 10 mM EDTA, and 1% SDS) containing 1×
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30 min. Chromatin was sonicated to an average size of
approximately 1000 bp with a Virsonic 475 sonicator and a
microtip (Virtis, Gardiner, NY) for a total of 100 s using 20-s
pulses with 10-s breaks at the setting of 4.5. Chromatin was
precleared with 20 μl blocked Staph A cells (Sigma) at 4 °C
rotating for 30 min. After preclearing, 10% of each sample was
taken for DNA input before immunoprecipitation. Samples were
diluted to 600 μl with immunoprecipitation (IP) dilution buffer
(0.01% SDS, 1.1% Triton X-100, 1.2 mM EDTA, 16.7 mM
Tris–Cl, pH 8.1, and 167 mM NaCl). Samples were immuno-
precipitated with 10 μg rabbit anti-Ac-H3 antibody 06-599
(Upstate, Lake Placid, NY), which recognizes acetylated K9 and
K14, or 3 μg rabbit anti-M3K4-H3 antibody ab8580 (Abcam,
Cambridge, MA) at 4 °C rotating overnight. Normal rabbit IgG
antibody I5006 (Sigma) was used as an immunoglobulin IP
control. Immunoprecipitates were pulled down with 20 μl of
blocked Staph A at 4 °C rotating for 15min. Immunoprecipitates
were washed twice with 1× dialysis buffer (2 mMEDTA, 50mM
Tris–Cl, pH 8.0, and 0.2% Sarkosyl) and four times with IP wash
buffer (100 mM Tris–Cl, pH 8.0, 500 mM LiCl, 1% NP40, and
1% deoxycholic acid) at room temperature rotating for 3 min.
DNA–protein complexes were eluted twice with 150 μl fresh
elution buffer (50 mM NaHCO3 and 1% SDS) at room
temperature rotating for 30 min. Cross-links were reversed by
adding 1 μl 10 mg/ml RNase A (Sigma), 18 μl 5 M NaCl, and
incubating complexes at 67 °C for 4 h. DNAwas then ethanol-
precipitated. Samples were suspended in 100 μl TE, pH 8.0,
25 μl 5× proteinase K buffer (50 mM Tris–Cl, pH 7.5, 25 mM
EDTA, and 1.25% SDS), and 1.5 μl 10 mg/ml proteinase K and
incubated at 45 °C for 2 h. DNA was purified by using the
QIAquick PCR purification kit (Qiagen, Valencia, CA). DNA
was eluted in 32 μl QIAquick elution buffer. As a positive
control, THP-1 cells were treated with PMA and HC
immediately after transduction (data not shown).
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